The Trump administration has expanded access to nicotine products despite concerns from public health critics about youth use ...
The FDA’s decision gives Philip Morris a powerful new claim for Zyn—and raises a bigger question about whether nicotine ...
“It’s a real commercial win but not a new revenue stream out of nowhere,” one analyst said of the new risk claim greenlit by ...
Forbes contributors publish independent expert analyses and insights. Jesse Pines is an expert in healthcare innovation and wellness. This voice experience is generated by AI. Learn more. This voice ...
Philip Morris International's U.S. businesses (PMI U.S.) today announced the launch of the ZYN America250 Art Series, a cultural initiative from America's No. 1 nicotine pouch brand, celebrating the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results